🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 1-year, open-label, long-term safety extension for patients who h...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-10
Trial ID
NCT00199368
Treatments Being Tested
To establish the efficacy of 10, 20 and 40 mg/d dose of istradefylline for ...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-07
Trial ID
NCT00199420
Treatments Being Tested
This is an investigator-initiated trial. In this 6-month open label, single...
Status
Completed
Location
Georgetown University Hospital
Start Date
2023-01-20
Trial ID
NCT05885360
Treatments Being Tested
The purpose of this study is to establish the efficacy of 20 mg/day and 40 ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00955526
Treatments Being Tested
The purpose of this study is to confirm the long term tolerability and safe...
Status
Completed
Location
The University of Chicago
Start Date
2005-03
Trial ID
NCT00203957
Treatments Being Tested
Acute Intermittent Hypoxia (AIH) is a rehab approach attributed to serotoni...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07704385
Treatments Being Tested
Patients with Parkinson's disease who completed the prior double-blind stud...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00957203
Treatments Being Tested
To establish the efficacy of a 20 mg/day dose of istradefylline for reducin...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-06
Trial ID
NCT00199407
Treatments Being Tested
The purpose of this research study is to determine the effects of a medicat...
Status
Active Not Recruiting
Location
Clinical and Translational Research Building
Start Date
2022-06-21
Trial ID
NCT05377424
This is a Phase 3, 52-week, open-label, flexible-dose, multinational, multi...
Status
Completed
Location
Kyowa PD Site
Start Date
2015-12
Trial ID
NCT02610231
Treatments Being Tested